Im Cannabis Corp Asset Resilience Ratio
Im Cannabis Corp asset resilience ratio. Im Cannabis Corp (IMCC) has an Asset Resilience Ratio of 1.11% as of March 2022. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Im Cannabis Corp (IMCC) defensive interval to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of Im Cannabis Corp (2004–2021)
Asset resilience ratio of Im Cannabis Corp from 2004 to 2021. This chart shows how Im Cannabis Corp's Asset Resilience Ratio has changed over time. Read IMCC current and long-term liabilities for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down Im Cannabis Corp's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see IMCC total asset value.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $3.13 Million | 1.11% |
| Total Liquid Assets | $3.13 Million | 1.11% |
Asset Resilience Insights
- Limited Liquidity: Im Cannabis Corp maintains only 1.11% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Im Cannabis Corp Industry Peers by Asset Resilience Ratio
Compare Im Cannabis Corp's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Viatris Inc
NASDAQ:VTRS |
Drug Manufacturers - Specialty & Generic | 1.48% |
|
Tianjin Zhongxin Pharmaceutical Group Corp Ltd
SHG:600329 |
Drug Manufacturers - Specialty & Generic | 5.92% |
|
Walvax BioTech
SHE:300142 |
Drug Manufacturers - Specialty & Generic | 2.20% |
|
Curaleaf Holdings Inc.
TO:CURA |
Drug Manufacturers - Specialty & Generic | 3.73% |
|
Tianjin Chase Sun Pharmaceutical Co Ltd
SHE:300026 |
Drug Manufacturers - Specialty & Generic | -0.89% |
|
Changzhou Qianhong Biopharma Co Ltd
SHE:002550 |
Drug Manufacturers - Specialty & Generic | 18.70% |
|
Renhe Pharmacy Co Ltd
SHE:000650 |
Drug Manufacturers - Specialty & Generic | 37.54% |
|
Harbin Gloria Pharmaceuticals
SHE:002437 |
Drug Manufacturers - Specialty & Generic | 9.04% |
Im Cannabis Corp Asset Resilience Ratio by Year (2004–2021)
Im Cannabis Corp asset resilience ratio by year from 2004 to 2021. The table below shows the annual Asset Resilience Ratio data for Im Cannabis Corp.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2021-12-31 | 1.09% | $3.13 Million | $287.39 Million | -- |
| 2020-12-31 | 0.00% | $0.00 | $38.12 Million | -- |
| 2005-12-31 | 17.15% | $189.00K | $1.10 Million | -2.45pp |
| 2004-12-31 | 19.59% | $225.00K | $1.15 Million | -- |
About Im Cannabis Corp
IM Cannabis Corp. engages in importation, distribution and sale of medical cannabis products in Israel and Germany. It provides medical cannabis dried flowers; and full-spectrum cannabis extracts under the IMC, BLKMT, and LOT420 brands. The company serves medical patients. IM Cannabis Corp. was founded in 2008 and is headquartered in Vancouver, Canada.